header advert
The Bone & Joint Journal Logo

Receive monthly Table of Contents alerts from The Bone & Joint Journal

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Open Access

Trauma

Vascular impulse technology versus elevation for the reduction of swelling of lower extremity joint fractures: results of a prospective randomized controlled study



Download PDF

Abstract

Aims

Complex joint fractures of the lower extremity are often accompanied by soft-tissue swelling and are associated with prolonged hospitalization and soft-tissue complications. The aim of the study was to evaluate the effect of vascular impulse technology (VIT) on soft-tissue conditioning in comparison with conventional elevation.

Methods

A total of 100 patients were included in this prospective, randomized, controlled monocentre study allocated to the three subgroups of dislocated ankle fracture (n = 40), pilon fracture (n = 20), and intra-articular calcaneal fracture (n = 40). Patients were randomized to the two study groups in a 1:1 ratio. The effectiveness of VIT (intervention) compared with elevation (control) was analyzed separately for the whole study population and for the three subgroups. The primary endpoint was the time from admission until operability (in days).

Results

The mean length of time until operability was 8.2 days (SD 3.0) in the intervention group and 10.2 days (SD 3.7) in the control group across all three fractures groups combined (p = 0.004). An analysis of the subgroups revealed that a significant reduction in the time to operability was achieved in two of the three: with 8.6 days (SD 2.2) versus 10.6 days (SD 3.6) in ankle fractures (p = 0.043), 9.8 days (SD 4.1) versus 12.5 days (SD 5.1) in pilon fractures (p = 0.205), and 7.0 days (SD 2.6) versus 8.4 days (SD 1.5) in calcaneal fractures (p = 0.043). A lower length of stay (p = 0.007), a reduction in pain (ppreop = 0.05; pdischarge < 0.001) and need for narcotics (ppreop = 0.064; ppostop = 0.072), an increased reduction in swelling (p < 0.001), and a lower revision rate (p = 0.044) could also be seen, and a trend towards fewer complications (p = 0.216) became apparent.

Conclusion

Compared with elevation, VIT results in a significant reduction in the time to achieve operability in complex joint fractures of the lower limb.

Cite this article: Bone Joint J 2021;103-B(4):746–754.

Take home message

Vascular impulse technology therapy results in a faster operability compared to elevation, reduces pain, and tends to reduce the soft-tissue-related revision rate and swelling reduction compared to elevation.

It is a low-complication, useful adjunct to soft-tissue conditioning of complex lower limb fractures, when used for at least six to eight hours per day.

Introduction

With an incidence of 174/100,000 per year, ankle joint fractures are the most common fracture of the lower limb.1 Tibial pilon and intra-articular calcaneal fractures, each with an incidence of 10 to 15/100,000 per year, however, represent only a minor proportion.2 But, because of the joint involvement with an usually serious damage to the articular surface, they are challenging injuries accompanied by many complications.3-6 The basis for a good clinical outcome and high functionality in these joint fractures is surgical management with anatomical reposition.4,7,8

Definitive internal osteosynthesis cannot be undertaken until the swelling of the surrounding soft tissues has resolved.9,10 This post-traumatic swelling is due to two main components: haemorrhage of the injured vessels and soft-tissue contusion. The subsequent soft-tissue oedema leads to a cycle of an ischaemia-related increase in vascular permeability followed by increased compartmental pressures, which in turn intensify the ischaemia by reducing the microcirculation.11-17 This trauma-induced damage to the microcirculation starts around one to two hours after trauma, needs time to fully develop and usually reaches a peak after 24 to 72 hours.18-22 This results in an increased risk of wound infections, wound healing disorders, and compartment syndromes.9,23,24 In addition, because of pressure and hypoxaemia with the accumulation of toxic metabolites in the tissue, the swelling results in increased pain and an increased analgesia requirement.24-27

Conventional methods such as elevation and cooling produce a sufficient reduction in swelling, permitting internal osteosynthesis in about ten days.28,29 Alternatively, vascular impulse technology (VIT) a form of intermittent pneumatic compression (IPC) may be used for soft-tissue conditioning. These pumps were originally developed for thrombosis prophylaxis in the 1980s by Gardner and Fox.30 The authors were able for the first time to document the physiology of venous return via a venous foot pump by videophlebography. Based on these results, they developed the first pump for IPC with impulse technology, which induces a pulse-like venous return via the foot plexus.31

As a result of this enhanced venous return and assisted lymphatic removal, the resolution of swelling is accelerated, and the complication risk should be reduced.32,33 Some studies have already described a stronger effect of this on swelling than conventional elevation in simple ankle joint fractures.34,35 However, as systematic reviews have shown, the clinical benefit of VIT in joint fractures of the lower limb with clinically relevant soft-tissue swelling has yet to be sufficiently investigated.36-38

The hypothesis of this study is that operability can be achieved more rapidly by means of VIT than by elevation in complex joint fractures of the lower limb.

Methods

This study was planned as a randomized, controlled, prospective, monocentre trial with a parallel group design to evaluate the efficacy of VIT compared with conventional elevation in complex joint fractures. Blinding could not be performed because of the apparent difference in how the attending staff were treated. Patients did not receive any form of payment for their participation.

The study was registered in the German Clinical Trials Registry (DRKS00010510), and approval was given by the Ethics Committee of the Rhineland-Palatinate State Medical Association (837.155.16/10474). The study protocol was published before subject recruitment began.39

After signing an informed consent form, patients aged 18 to 80 years with isolated ankle fracture dislocation, tibial pilon fracture type B/C according to AO,40 or intra-articular calcaneal fracture were included, who required hospitalization and were unable to be definitively treated on the day of admission, i.e. by open reduction and internal fixation (ORIF).

Patients under 18 or over 80 years of age, who had not signed an informed consent form or who had additional limb injuries or local soft-tissue complications (infections, tension blisters, necrosis, compartment syndrome) were excluded. Further exclusion criteria included outpatient treatment, open fractures, decompensated heart failure, acute phlebitis, thrombosis or pulmonary artery embolism, drug or alcohol abuse, current imprisonment, pregnancy, or participation in another clinical trial.

Randomization

Randomization was performed in a 1:1 ratio for all three subgroups separated into permuted blocks of the same length by the web-based programme “Randoulette” (https://wwwapp.ibe.med.uni-muenchen.de/randoulette/index.jsp) on the day of enrolment, and the data were stored in pseudonymized form. Blinding of the subjects or study team was not feasible because of the acoustically and visually apparent intervention from the use of the VADOplex device.

Study procedure and data collection

The detailed description of the study procedure, data collection, and dropouts is outlined in Figure 1. Following randomization of the subjects, VIT therapy was administered in the intervention group by means of the VADOplex system (OPED, Oberlaindern, Germany). This involves a compressor inflating a connected air pad in less than half a second with a pressure of 130 mmHg and then deflating it again. This air pad stimulates the venous foot plexus in the sole of the foot at 20-second intervals and thus causes a pulse-like venous return which is triggered just as effectively as by full weight-bearing on walking.34 As long as the VIT therapy was running, the study group discontinued elevation and rested the leg below heart level to achieve sufficient priming of the veins. The control group received only continuous elevation of the injured limb in an elevation pillow as a measure to reduce swelling. Both treatments were intended to be used for the whole day and the VIT therapy explicitly for at least six hours to eight hours daily. No further measures were used to reduce the swelling in either group.

Fig 1 
            Flowchart of patients through the study. VIT, vascular impulse technology.

Fig 1

Flowchart of patients through the study. VIT, vascular impulse technology.

Pending definitive internal osteosynthesis, all ankle and pilon fractures were initially stabilized and immobilized by an external fixator and every calcaneal fracture by a lower leg vacuum orthosis on the day of admission. The patients in both groups were immobilized preoperatively. Postoperatively, mobilization was performed by starting with partial weight-bearing for two weeks followed by a weekly increased weight-bearing of 10 kg to 20 kg until full weight-bearing was achieved. As long as full weight-bearing had not been achieved, both groups received DVT prophylaxis by administration of a low molecular weight heparin once daily.

The primary endpoint of the study was the time from hospital admission until operability (in days), which was evaluated daily by an independent observer (one of two independent consultants). Similar to previous studies, limbs were deemed suitable for surgery as soon as the wrinkle sign turned positive.9,41 This involved observing whether the physiological skin folds were visible again on eversion and dorsal extension of the foot. If this was the case, then the swelling had been sufficiently reduced to permit surgery. If not, the patient was not fit for surgery. A correlation analysis conducted as part of a preliminary study revealed almost complete consistency (κ = 0.816) between the two independent observers in terms of the assessment of operability.

Data on the secondary endpoints were also collected daily through a study visit. Secondary endpoints were: duration of hospitalization (days); pain on a visual analogue scale (VAS); as well as analgesia requirement (in accordance with the World Health Organization (WHO) step system42); and soft tissue swelling. The WHO step system consists of three steps, starting with the sole use of non-opioid analgesics in step 1. In step 2, low-potency opioids are added and in step 3 high-potency opioids. Soft-tissue swelling was calculated from the increase in circumference (in %) at the level of the smallest circumference of the lower leg and the level of the instep compared to the uninjured contralateral side. Since the aim was to analyze the effectiveness of swelling reduction, we presented the reduction in swelling per day in the VIT group in relation to the value in the control group (in %). In addition, complications and revision procedures during hospitalization were recorded. Complications were defined as any emerging condition requiring additional treatment, and revision procedure as any condition leading to a readmission to the operating theatre.

Statistical analysis

The primary problem statement concerned whether there was a difference in the time from hospitalization to operability between the treatment groups (VIT and conventional elevation). The target number of cases was 20 subjects per group (per fracture) to be able to demonstrate a reduction in the mean time from hospitalization to operability from seven days to five days (SD 2) with a significance level of 5%, a power of 80% and allowing for a dropout rate of 15%. The parameters are based on an earlier study of the effectiveness of IPC in simple ankle joint fractures.34 This resulted in a total sample size of 40 subjects per fracture.

All data were described with suitable measurements of central tendency and dispersion. The analysis of the primary endpoint (difference in time from hospitalization to operability) was performed using a Welch's t-test (for unequal variances) based on the “intention-to-treat” (ITT) population. A modified ITT was used, since two patients were treated conservatively and therefore a value for the primary endpoint was non-existent. Sensitivity analyses were performed on the “as treated” (AT) and “per protocol” (PP) population. The secondary endpoints were analysed exploratorily by suitable statistical analysis:for continuous variables, differences were assessed using Welch's t-tests with adjustment for unequal variances, for ordinally scaled variables Mann-Whitney U tests were used, and for nominal scaled variables chi-squared tests were used). Multiple linear regression analyses were performed to investigate potential effects of five demographic characteristics (sex, age, smoking, educational level, previous disease treated by medication) on the primary endpoint.

Statistical analyses were performed using R v. 3.6.0 (R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was set at p ≤ 0.05.

Results

Both groups were comparable in terms of demographic characteristics (such as age, sex, concurrent diseases, and smoking) and fracture severity (fracture classification, ISS, injury mechanism) except for educational level (whether or not a degree has been obtained from a university) (Table I). In the VIT group 16 patients required treatment for a pre-existing medical condition versus 21 in the control group (p = 0.230). Pre-existing conditions were comparable between both groups, mostly being high blood pressure (n = 22) or hypothyroidism (n = 11).

Table I.

Demographic data.

Variable Intervention

(n = 50)
Control

(n = 48)
p-value
Age, mean (SD) 50.2 (15.4) 51.6 (14.6) 0.649*
Injury, n (%)
Ankle 20 (40) 20 (41.7)
Pilon 10 (20) 10 (20.8)
Calcaneus 20 (40) 18 (37.5)
AO ankle fracture type, n (%) 0.741
B 6 (30) 8 (40)
C 14 (70) 12 (60)
AO pilon fracture type, n (%) > 0.999
B 3 (30) 3 (30)
C 7 (70) 7 (70)
Calcaneal fracture Sanders type, n (%) 0.529
II 5 (25) 2 (11)
III 10 (50) 10 (56)
IV 5 (25) 6 (33)
Injury Severity Score 0.908
Median (IQR) 4 (0) 4 (0)
Mean (SD) 4.4 (1.2) 4.3 (1.0)
Injury mechanism, n (%) 0.260
Low-energy 39 (78) 32 (67)
High-energy 11 (22) 16 (33)
Sex, n (%) 0.567
Male 36 (72) 32 (66.7)
Female 14 (28) 16 (33.3)
Academic degree, n (%) (n = 48) (n = 41) 0.040
Yes 16 (33.3) 5 (12.2)
No 32 (66.7) 36 (87.8)
Disease requiring treatment, n (%) 0.230
Yes 16 (32) 21 (43.8)
No 34 (68) 27 (56.2)
Smoker, n (%) 0.225
Yes 14 (28) 19 (39.6)
No 36 (72) 29 (60.4)
Side, n (%) 0.213
Right 25 (50) 30 (62.5)
Left 25 (50) 18 (37.5)
  1. *

    Welch's t-test.

  1. Chi-squared test.

  1. Mann-Whitney U Test.

  1. IQR, interquartile range; SD, standard deviation.

Primary study parameter

The primary study parameter was analyzed using Welch's t-test for unequal variances. By mITT, the mean time to achieve operability was two days shorter in the intervention group than in the control group (p = 0.004, Welch's t-test; Figure 2; Table II). The sensitivity analyses (as treated: group membership according to treatment; per protocol: without crossovers) revealed similar results with a difference of -3.2 days (SD 0.6; 95% confidence interval (CI) -4.3 to -2.0; p < 0.001, Welch's t-test). In Table II, the detailed results of the analysis by mITT is illustrated by individual fractures. In the AT population the difference increased to -2.1 days (SD 0.9) in the ankle, -6.1 days (SD 1.5) in the pilon and -2.3 days (SD 0.6) in the calcaneus group. Comparing the younger population with an age below 55 years to the older patients we found an increase in the primary endpoint of 0.7 days (SD 0.7; p = 0.683, Welch's t-test). The difference was higher in the control group with a difference of 1.4 days (SD 1.0) in favour of the older patients and 0.1 days (SD 0.9) in the VIT group (pc = 0.397; pVIT = 1.000, Welch's t-test).

Fig. 2 
            Boxplot showing time from hospitalization to operability. VIT, vascular impulse technology.

Fig. 2

Boxplot showing time from hospitalization to operability. VIT, vascular impulse technology.

Table II.

Primary and secondary endpoints.

Primary endpoint nVIT/ nK VIT (n = 50) Control (n = 48) p-value
Time hospitalization to operability, mean (SD)
Overall
mITT 50/48 8.2 (3.0) 10.2 (3.7) 0.004*
AT 37/61 7.2 (2.2) 10.3 (3.5) < 0.001*
Ankle
mITT 20/20 8.6 (2.2) 10.6 (3.6) 0.043*
AT 15/25 8.3 (2.1) 10.3 (3.4) 0.024*
Pilon
mITT 10/10 9.8 (4.1) 12.5 (5.1) 0.205*
AT 4/16 6.3 (2.1) 12.4 (4.3) 0.002*
Calcaneus
mITT 20/18 7.0 (2.6) 8.4 (1.5) 0.043*
AT 18/20 6.5 (2.1) 8.8 (1.9) 0.001*
Secondary endpoints
Mean pain intensity, VAS (SD)
Admission 50/48 2.14 (1.86) 1.96 (1.05) 0.552*
Preop 41/48 0.66 (0.85) 1.17 (0.78) 0.005*
Postop 38/46 2.16 (1.91) 3.15 (1.59) 0.013*
Discharge 30/36 0.37 (0.67) 1.08 (0.55) < 0.001*
Mean narcotics requirement, d (SD)
Preop 41/47 8.2 (10.3) 12.2 (9.5) 0.064*
Postop 30/36 6.8 (7.7) 11.3 (11.9) 0.072*
Overall complications, n (%) 50/48 5 (10) 9 (18.8) 0.216
Overall revisions, n (%) 50/48 1 (2) 6 (12.5) 0.044
Median hospitalizations (IQR) 50/48 17.0 (14.3 to 21.0) 21.0 (16.8 to 24.0) 0.007§
Preop Postop p-value
Mean swelling reduction/day, % (SD) 77.8 (55) 12.4 (0.1) < 0.001*
  1. *

    Welch's t-test.

  1. Percentages are derived from cases occurring in the corresponding group by ITT.

  1. Chi-squared test.

  1. §

    Mann-Whitney U test.

  1. AT, as treated; IQR, interquartile range; ITT, intention to treat; mITT, modified intention-to-treat; SD, standard deviation; VAS, visual analogue scale; VIT, vascular impulse technology.

Secondary study parameters

Analyzing the secondary endpoints, the median length of stay (LOS) of 17 days (14.5 to 21.0) in the intervention group was shown to be four days shorter than that in the control of 21 days (16.75 to 24.00; p = 0.007; Mann-Whitney U test). The subjects in the VIT group experienced reduced pain intensity (VA) from the beginning of treatment in comparison to the control (reduction by 0.51 preoperatively; (p = 0.050, Welch's t-test), 0.93 postoperatively (p = 0.013, Welch's t-test), and 0.71 on discharge; (p < 0.001, Welch's t-test) (Table II, Figure 3). During hospitalization, analgesia use in the two groups was comparable (Table III). On discharge, 70% (21/30) of patients in the VIT group were pain-free. By comparison, 11.1% (4/36) of the patients in the control group were pain-free on discharge (p < 0.001, Welch's t-test). Preoperatively, the study patients required narcotics in their pain medication for 4.0 days (SD 2.1) less (p = 0.064, Welch's t-test) and postoperatively for 4.5 days (SD 2.4) less (p = 0.072, Welch's t-test) than the patients in the control group (Table II).

Fig. 3 
            Boxplot showing pain intensity. VAS, visual analogue scale; VIT, vascular impulse technology.

Fig. 3

Boxplot showing pain intensity. VAS, visual analogue scale; VIT, vascular impulse technology.

Table III.

Secondary endpoints.

Secondary endpoints nVIT/ nK VIT group (n = 50) Control group (n = 48) p-value
Complications, n (%)*
Ankle 20/20 2 (10) 5 (25) 0.212
Pilon 10/10 2 (20) 3 (30) 0.606
Calcaneus 20/18 1 (5) 1 (5.5) 0.939
Revisions, n (%)*
Ankle 20/20 1 (5) 3 (15) 0.292
Pilon 10/10 0 (0) 3 (30) 0.060
Calcaneus 20/18 0 (0) 0 (0)
Median hospitalization (IQR)
Ankle 20/20 17.0

(14.5 to 21.0)
18.0

(15.0 to 22.3)
0.166
Pilon 10/10 17.0

(15.3 to 24.0)
23.5

(21.0 to 26.8)
0.111
Calcaneus 20/18 17.0

(14.0 to 20.0)
21.5

(17.3 to 22.8)
0.081
Analgesiapreop

n (%)
Ankle 17/20
WHO Step 0 1 (5.9) 0 (0)
WHO Step 1 12 (70.6) 16 (80)
WHO Step 2 0 (0) 0 (0)
WHO Step 3 4 (23.5) 4 (20)
Pilon 5/10
WHO Step 0 0 (0) 0 (0)
WHO Step 1 4 (80) 5 (50)
WHO Step 2 0 (0) 0 (0)
WHO Step 3 1 (20) 5 (50)
Calcaneus 19/17
WHO Step 0 2 (10.5) 0 (0)
WHO Step 1 14 (73.7) 14 (82.4)
WHO Step 2 0 (0) 0 (0)
WHO Step 3 3 (15.8) 3 (17.6)
Analgesiadischarge

n (%)
Ankle 11/17
WHO Step 0 3 (27.3) 0 (0)
WHO Step 1 8 (72.7) 16 (94.1)
WHO Step 2 0 (0) 0 (0)
WHO Step 3 0 (0) 1 (5.9)
Pilon 4/6
WHO Step 0 1 (25) 0 (0)
WHO Step 1 3 (75) 6 (100)
WHO Step 2 0 (0) 0 (0)
WHO Step 3 0 (0) 0 (0)
Calcaneus 15/13
WHO Step 0 2 (13.3) 0 (0)
WHO Step 1 13 (86.7) 13 (100)
WHO Step 2 0 (0) 0 (0)
WHO Step 3 0 (0) 0 (0)
  1. *

    Percentages are derived from cases occurring in the corresponding group by ITT.

  1. Chi-squared test.

  1. Mann-Whitney U test.

  1. IQR, interquartile range; ITT, intention to treat; VIT, vascular impulse technology; WHO, World Health Organization.

Over all fracture groups combined, we saw a significant increase in swelling reduction in the VIT group by 77.8% (SD 55) preoperatively and by 12.4% (SD 0.1) postoperatively measured as mean of the swelling in % around the smallest girth of the calf and the instep (ppreop < 0.001 and ppostop < 0.001, Welch's t-test; Table II).

Complications and revisions

The complication rate of 10% (5/50) in the intervention group was lower than that in the control group of 18.8% (9/48), but without a significant difference (p = 0.216, chi-squared test). We saw five wound healing problems (VIT 1; control 4), three cases of challenging postoperative oedema (VIT 2, control 1), one bleeding from a pin site (VIT 1, control 0), one pressure ulcer (VIT 1, control 0), two subluxations in an external fixator (VIT 0, control 2), and two cases of deep infection (VIT 0, control 2). In the intervention group, a revision was performed in one patient (2%) (secondary suture following intraoperative VAC) while in the control group, six patients (12.5%) underwent revision (two compartment releases on the day after ORIF of a pilon fracture, two corrections of external fixator, one debridement and metal removal due to plate infection, one wound revision of tibial pin site and secondary suture laterally), representing a significant difference (p = 0.044, chi-squared test). Overall, the complication rate was slightly higher among the younger patients with 16% (10/62) compared to 11% (4/36) in the older patients (p = 0.564, chi-squared test).

Regression analyses

The regression analyses (duration~ group + demographic characteristics; Table IV) only showed a significant mean reduction for women by 1.8 days in the time to operability compared with men (p = 0.013; estimator factor group -2.08, p = 0.002). This reduction was only seen in the control group and not in the intervention group as well. No differences in duration were observed for the characteristics “age”, “academic” (defined by a university degree), “disease requiring treatment” (i.e. anticoagulative drugs), or “smoker”.

Table IV.

Regression analyses.

Model variables Estimator* SE p-value
Group -2.025 0.669 0.003
Age -0.028 0.023 0.224
Group -2.082 0.653 0.002
Sex (ref. men) -1.792 0.709 0.013
Group -1.823 0.737 0.015
Academic -1.218 0.865 0.163
Group -2.040 0.677 0.003
Disease requiring treatment -0.457 0.698 0.514
Group -1.996 0.679 0.004
Smoker -0.078 0.718 0.914
  1. *

    Interpretation of the estimator: For categorial variables, the estimator indicates the change in time from hospitalization to operability in the variable indicated compared with the reference category. Therefore in the Time ~ Group + Age model, for example, the time from hospitalization to operability in the VIT group is reduced by 2.025 days (because of a negative sign) compared with the control group. For continuous variables, theestimator describes the change in the time from hospitalization until operability with an increase in the continuous variables by 1.

  1. Welch's t-test.

  1. The estimator relates to the intensity of the characteristic concerned.

  1. SE, standard error.

Discussion

Venous foot pumps were developed following the discovery of the venous foot plexus and its physiology in the prevention of deep vein thrombosis (DVT).33 Several studies were conducted in this respect and demonstrated a prophylactic effect, particularly in major orthopaedic surgery, such as total hip arthroplasty, with a lower incidence of pulmonary embolisms.32,33,43-47 Few studies to date have considered the benefit and effectiveness of VIT therapy on reducing swelling in fractures of the limbs.34,48-53 Studies published so far relate mostly to small study populations or limited indications. Stranks et al54 in 1992 demonstrated a swelling-reducing effect of IPC. With a treatment period of 15 hours daily, there was a reduction in swelling of up to 3 cm in the hip and 1.5 cm in the calf. In 2004, Caschman et al34 conducted the only randomized controlled trial (RCT) of the present question to date. The authors specifically investigated the benefit of IPC for soft-tissue conditioning. In the case of simple, unimalleolar ankle joint fractures, a significantly more rapid reduction in swelling and a decrease in the soft-tissue complication risk was demonstrated with IPC compared with elevation. A further study by Dodds et al48 from 2014 also demonstrated a positive effect of IPC. The authors reported that the patients in the intervention group were able to undergo surgery and be discharged one day earlier. The rate of wound infections decreased from 11% (8/73) in the control group to 3% (2/64) in the intervention group. However, more than half the cases involved unimalleolar ankle fractures, and a retrospective cohort was used as control. In a study by Arndt et al,53 it was also examined whether IPC can help reduce the time to surgery in malleolar fractures. However, they used a device reaching from toe to the hip and performed treatment during elevation, both of which do not resemble the physiological function of the venous foot pump. With a mean time to surgery of around 22 hours in the study and the control group, their study design was inadequate to investigate prolonged preoperative hospitalization because of soft-tissue swelling. Alkner et al51 used a protocol for distal radial fractures in which IPC was first used after four weeks of post-surgical immobilization and Yamazaki et al,52 who also investigated the effect in distal radial fractures, used a non-physiological treatment protocol consisting of a continuous pressure of 20 mmHg.

All the discussed methodological weaknesses and potential sources of bias have also been covered in the systematic reviews of Winge et al37 and Clarkson et al36 that were published almost simultaneously in 2017. They also noted that despite this supporting evidence for the usage of IPC, surgeons still mostly use only passive methods for soft-tissue conditioning. These reviews and the medical guideline on IPC from 2018 came to the conclusion that, based on the available evidence, no valid conclusion can be drawn regarding the use of IPC on post-traumatic swelling and its effect in clinical outcomes. Further, well-designed studies are needed to assess their significance in perioperative fracture management.45

The literature results were confirmed in the present RCT study. The patients in the intervention group achieved operability significantly earlier. In the case of ankle fracture dislocation, operability was achieved two days faster, in intra-articular calcaneal fractures 1.4 days faster and in tibial pilon fractures almost 2.7 days faster. Intra-articular calcaneal fractures and pilon fractures, in particular, are associated with a high rate of soft-tissue complications, as the soft-tissue lining is very thin and the effect of force in these fractures is very marked.3-5

A significant effect of VIT therapy was also demonstrated in the present study in terms of the reduction in soft tissue swelling: preoperatively we achieved a faster oedema reduction by 77.8% and postoperatively by 12.4% in the study group. The lower difference postoperatively might be due to the lower swelling already achieved because of the better soft-tissue conditioning preoperatively, supported by the lower swelling in the VIT group with a median of 2.3 cm (1.5 to 3.6) versus 3.0 cm (1.5 to 4.0) in the control group. In this study, fewer complications (10% vs 18.8%) occurred in the intervention group. Revision surgery was performed in one patient in the intervention group (2.0%) and in four patients in the control (8.3%) for a soft-tissue-related complication. Furthermore, the patient in the intervention group reported significantly less pain with a relevant shorter dependence on narcotics in the medication, possibly as a result of improved microcirculation and increased venous return associated with lymphatic effects.21 It may therefore be concluded that VIT therapy represents an effective tool for soft-tissue conditioning even in critical soft-tissue conditions. This is further confirmed by the comparison between the older and the younger study population. Among the older group no increase and even a slight decrease in preoperative hospitalization and complication rate could be found. Thus, it can be concluded that these groups are comparable and the VIT therapy seems to be an effective tool especially in older patients.

The small number of cases of tibial pilon fractures with only half the calculated sample size may be mentioned as a limitation of the study. This is because this patient population met too many exclusion criteria, primarily often presenting with bilateral injuries or serious soft-tissue complications such as compartment syndrome and tension blisters upon admission. To avoid protracting the course of this study further by an estimated three years until the planned number of cases may be achieved, we refrained from including a further 20 patients. A further limitation of the study is the number of patients who could not comply with the VIT therapy. A total of six patients discontinued the study intervention because of pain on use (n = 3) or complications (n = 3). The majority of protocol violators (n = 7% and 14% of all intervention patients) failed to use the device adequately. Frequently reported reasons for this were the noise associated with use or lack of interest. The treatment duration of VIT therapy recommended by the manufacturer and also in other studies is at least six to eight hours daily for sufficient benefit to be obtained. An effective benefit of VIT therapy can therefore only be achieved with sufficient patient compliance or monitoring, a conclusion also drawn by Braithwaite et al55 in their feasibility study on the use of in-plaster VIT as thrombosis prophylaxis.55

The recording of the primary endpoint constitutes a further limitation of the study. The primary endpoint, operability, was determined by two independent physicians based on the “wrinkle sign”. The subjectivity of this parameter was offset to a certain extent by the fact that this parameter was recorded by two independent consultants at the hospital, between whom a very good correlation in such recording had been demonstrated in a previous study (κ = 0.816). In comparable earlier studies, operability was also used as a primary study parameter and “wrinkle sign” was given as a relevant criterion for this.29,49,56-63 Furthermore, a significantly faster reduction in swelling was found in the VIT group. The validity of these data, however, is somewhat limited because of the error-prone measurement method using a tape measure and because of the large measurement error when measuring in 5 mm steps. To limit this error, circumference measurements were recorded daily and calculated from the reduction in swelling/day in % for the analysis of the mean. The previous studies mostly used volumetric measurements to determine the reduction in swelling. In the present study, unstable joint fractures were included for the most part, which in some cases were stabilized externally with a fixator. A volumetric measurement would therefore only have been possible to a limited extent, if at all.

In complex intra-articular fractures of the ankle, tibial pilon, and calcaneus, the use of IPC with vascular impulse technology (VIT) produces sufficient soft tissue conditioning and is superior to elevation alone. Operability is achieved on average at least two days earlier, reduction of swelling is accelerated, pain is decreased, and the usage of narcotics and rate of revision surgery tend to be reduced. VIT therapy therefore represents a helpful tool for soft-tissue conditioning in addition to other measures for reducing swelling, such as lymph drainage or elevation, and can be used as an adjunct to these in everyday clinical practice.


Correspondence should be sent to Marc Schnetzke. E-mail:

References

1. Elsen A , Eppinger M , Müller M . Orthopädie und Unfallchirurgie: Medizinische Verlags und Informationsdienste Breisach . 340 , 2016 . Google Scholar

2. Humphrey JA , Woods A , Robinson AHN . The epidemiology and trends in the surgical management of calcaneal fractures in England between 2000 and 2017 . Bone Joint J . 2019 ; 101-B ( 2 ): 140 146 . Crossref PubMed Google Scholar

3. Topliss CJ , Jackson M , Atkins RM . Anatomy of pilon fractures of the distal tibia . J Bone Joint Surg Br . 2005 ; 87-B ( 5 ): 692 697 . Crossref PubMed Google Scholar

4. Ivo M , Rupp M , Biehl C , Oberück S , Heiß C . Pilon-tibiale-Frakturen - Wann welche Platte? Übersicht über aktuelle Behandlungsstrategien zur Optimierung operativer Ergebnisse . OUP . 2019. ; 8 ( 4 ): 199 205 . Google Scholar

5. Burns AE . Fractures of the calcaneus . Clin Podiatry . 1985 ; 2 ( 2 ): 311 324 . Google Scholar

6. Bennett PM , Stevenson T , Sargeant ID , Mountain A , Penn-Barwell JG . Outcomes following limb salvage after combat hindfoot injury are inferior to delayed amputation at five years . Bone Joint Res . 2018 ; 7 ( 2 ): 131 138 . Crossref PubMed Google Scholar

7. Donken CC , Al-Khateeb H , Verhofstad MH , van Laarhoven CJ . Surgical versus conservative interventions for treating ankle fractures in adults . Cochrane Database Syst Rev . 2012 ; 8 : CD008470 . Crossref PubMed Google Scholar

8. El-Hawary A , Kandil YR , Ahmed M , Elgeidi A , El-Mowafi H . Distraction subtalar arthrodesis for calcaneal malunion: comparison of local versus iliac bone graft . Bone Joint J . 2019 ; 101-B ( 5 ): 596 602 . Crossref PubMed Google Scholar

9. Chou LB , Lee DC . Current concept review: perioperative soft tissue management for foot and ankle fractures . Foot Ankle Int . 2009 ; 30 ( 1 ): 84 90 . Crossref PubMed Google Scholar

10. Thordarson DB , Krieger LE . Operative vs. nonoperative treatment of intra-articular fractures of the calcaneus: a prospective randomized trial . Foot Ankle Int . 1996 ; 17 ( 1 ): 2 9 . Crossref PubMed Google Scholar

11. Tscherne H , Regel G . Unfallchirugie: Trauma-Management . XVI . New York: Springer : Berlin, Heidelberg , 1997 : 407 410 . Google Scholar

12. Menger MD , Kerger H , Geisweid A , et al. Leukocyte-Endothelium interaction in the microvasculature of postischemic striated muscle . Adv Exp Med Biol . 1994 ; 361 : 541 545 . Crossref PubMed Google Scholar

13. Menger MD , Rücker M , Vollmar B . Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of capillary "no-reflow" . Shock . 1997 ; 8 ( 1 ): 2 7 . PubMed Google Scholar

14. Menger MD , Vollmar B . In vivo analysis of microvascular reperfusion injury in striated muscle and skin . Microsurgery . 1994 ; 15 ( 6 ): 383 389 . Crossref PubMed Google Scholar

15. Subotnick SI . Compartment syndromes in the lower extremities . J Am Podiatry Assoc . 1975 ; 65 ( 4 ): 342 348 . Crossref PubMed Google Scholar

16. Szyszkowitz R , Reschauer R . [Etiology, pathophysiology and anatomical location of the compartment syndrome] . Langenbecks Arch Chir . 1982 ; 358 : 215 219 . [Article in German]CrossrefPubMed Google Scholar

17. Wolfárd A , Császár J , Gera L , et al. Endothelin-A receptor antagonist treatment improves the periosteal microcirculation after hindlimb ischemia and reperfusion in the rat . Microcirculation . 2002 ; 9 ( 6 ): 471 476 . Crossref PubMed Google Scholar

18. Schaser KD , Vollmar B , Menger MD , et al. In vivo analysis of microcirculation following closed soft-tissue injury . J Orthop Res . 1999 ; 17 ( 5 ): 678 685 . Crossref PubMed Google Scholar

19. Schaser K-D , Zhang L , Mittlmeier T , et al. Effect of soft tissue damage on fracture healing: intravital microscopic and biomechanical investigations in rats : Berlin, Heidelberg: Springer Berlin Heidelberg , 2003 : 9 11 . Google Scholar

20. Schaser KD . In-vivo-Analyse Der Mikrozirkulation in Skelettmuskel und Periost nACh geschlossenem Weichteiltrauma und Fraktur . Charité – Universitätsmedizin Berlin : Charité Berlin , 2005 . Google Scholar

21. Schaser KD , Zhang L , Haas NP , Mittlmeier T , Duda G , Bail HJ . Temporal profile of microvascular disturbances in rat tibial periosteum following closed soft tissue trauma . Langenbecks Arch Surg . 2003 ; 388 ( 5 ): 323 330 . Crossref PubMed Google Scholar

22. Zhang L , Bail H , Mittlmeier T , Haas NP , Schaser K-D . Immediate microcirculatory derangements in skeletal muscle and periosteum after closed tibial fracture . J Trauma . 2003 ; 54 ( 5 ): 979 985 . Crossref PubMed Google Scholar

23. Sirkin M , Sanders R , DiPasquale T , Herscovici D . A staged protocol for soft tissue management in the treatment of complex pilon fractures . J Orthop Trauma . 2004 ; 18 ( 8 Suppl ): S32 S38 . Crossref PubMed Google Scholar

24. Klotz M , Lessl E , Braatz F . Frakturen des unteren Sprunggelenks . 2012 : 28 31 . Google Scholar

25. Sandkühler J , Ärztebl D . Schmerzgedächtnis: Entstehung, Vermeidung und Löschung . 42 , 2001 :9898.2725–273027302725–27302730. Google Scholar

26. Blumberg H , Griesser HJ , Hornyak M . [Distal post-traumatic edema--symptom of a sympathetic reflex dystrophy (Sudeck's disease)?] . Z Orthop Ihre Grenzgeb . 1992 ; 130 ( 1 ): 9 15 . [Article in German]CrossrefPubMed Google Scholar

27. Schepers T , De Vries MR , Van Lieshout EMM , Van der Elst M . The timing of ankle fracture surgery and the effect on infectious complications; a case series and systematic review of the literature . Int Orthop . 2013 ; 37 ( 3 ): 489 494 . Crossref PubMed Google Scholar

28. Mora S , Zalavras CG , Wang L , Thordarson DB . The role of pulsatile cold compression in edema resolution following ankle fractures: a randomized clinical trial . Foot Ankle Int . 2002 ; 23 ( 11 ): 999 1002 . Crossref PubMed Google Scholar

29. Stöckle U , Hoffmann R , Schütz M , von Fournier C , Südkamp NP , Haas N . Fastest reduction of posttraumatic edema: continuous cryotherapy or intermittent impulse compression? Foot Ankle Int . 1997 ; 18 ( 7 ): 432 438 . Crossref PubMed Google Scholar

30. Gardner AM , Fox RH , Lawrence C , Bunker TD , Ling RS , MacEachern AG . Reduction of post-traumatic swelling and compartment pressure by impulse compression of the foot . J Bone Joint Surg Br . 1990 ; 72-B ( 5 ): 810 815 . Crossref PubMed Google Scholar

31. Morgan RH , Carolan G , Psaila JV , Gardner AMN , Fox RH , Woodcock JP . Arterial flow enhancement by impulse compression . Vasc Surg . 1991 ; 25 ( 1 ): 8 16 . Google Scholar

32. O'Connell S , Bashar K , Broderick BJ , et al. The use of intermittent pneumatic compression in orthopedic and neurosurgical postoperative patients: a systematic review and meta-analysis . Ann Surg . 2016 ; 263 ( 5 ): 888 889 . Crossref PubMed Google Scholar

33. Wilson NV , Das SK , Kakkar VV , et al. Thrombo-Embolic prophylaxis in total knee replacement. evaluation of the A-V impulse system . J Bone Joint Surg Br . 1992 ; 74-B ( 1 ): 50 52 . Crossref PubMed Google Scholar

34. Caschman J , Blagg S , Bishay M . The efficacy of the A-V impulse system in the treatment of posttraumatic swelling following ankle fracture: a prospective randomized controlled study . J Orthop Trauma . 2004 ; 18 ( 9 ): 596 601 . Crossref PubMed Google Scholar

35. Myerson MS , Henderson MR . Clinical applications of a pneumatic intermittent impulse compression device after trauma and major surgery to the foot and ankle . Foot Ankle . 1993 ; 14 ( 4 ): 198 203 . Crossref PubMed Google Scholar

36. Clarkson R , Mahmoud SSS , Rangan A , Eardley W , Baker P . The use of foot pumps compression devices in the perioperative management of ankle fractures: systematic review of the current literature . Foot . 2017 ; 31 : 61 66 . Crossref PubMed Google Scholar

37. Winge R , Bayer L , Gottlieb H , Ryge C . Compression therapy after ankle fracture surgery: a systematic review . Eur J Trauma Emerg Surg . 2017 ; 43 ( 4 ): 451 459 . Crossref PubMed Google Scholar

38. Hansrani V , Khanbhai M , Bhandari S , Pillai A , McCollum CN . The role of compression in the management of soft tissue ankle injuries: a systematic review . Eur J Orthop Surg Traumatol . 2015 ; 25 ( 6 ): 987 995 . Crossref PubMed Google Scholar

39. Schnetzke M , Swartman B , Bonnen I , et al. Vascular impulse technology versus elevation in the treatment of posttraumatic swelling of extremity fractures: study protocol for a randomized controlled trial . Trials . 2017 ; 18 ( 1 ): 73 78 . Crossref PubMed Google Scholar

40. Marsh JL , Slongo TF , Agel J , et al. Fracture and dislocation classification compendium - 2007: Orthopaedic Trauma Association Classification, Database and Outcomes Committee . J Orthop Trauma . 2007 ; 21 ( 10 Suppl ): S1 133 . Crossref PubMed Google Scholar

41. Harding D , Waddell JP . Open reduction in depressed fractures of the os calcis . Clin Orthop Relat Res . 1985 ; 199 : 124 31 . PubMed Google Scholar

42. Amrhein P , Kowalzik F , Likuski D , Michaelsen J , Rahden P , Rief M , et al. WHO-Stufenschema. In: I care - Krankheitslehre . Stuttgart : Georg Thieme Verlag , 2020 . Google Scholar

43. Ivanic GM , Moser I , Homann NC , Pietsch M , Kriechhammer P , Hennerbichler A . [Intermittent compression devices for swelling reduction and thrombosis prophylaxis--a pilot study after total hip replacement. Is the 2 hour daily minimum application sufficient?] . Unfallchirurg . 2006 ; 109 ( 9 ): 786 792 . Crossref PubMed Google Scholar

44. Saunders R , Comerota AJ , Ozols A , Torrejon Torres R , Ho KM . Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis . Clinicoecon Outcomes Res . 2018 ; 10 : 231 241 . Crossref PubMed Google Scholar

45. Schwahn-Schreiber C , Breu FX , Rabe E , et al. [S1 guideline on intermittent pneumatic compression (IPC)] . Hautarzt . 2018 ; 69 ( 8 ): 662 673 . [Article in German]CrossrefPubMed Google Scholar

46. Tyagi V , Tomaszewski P , Lukasiewicz A , Theriault S , Pelker R . The role of intraoperative intermittent pneumatic compression devices in venous thromboembolism prophylaxis in total hip and total knee arthroplasty . Orthopedics . 2018 ; 41 ( 1 ): e98 e103 . Crossref PubMed Google Scholar

47. Gonzalez Della Valle A , Shanaghan KA , Nguyen J , et al. Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty . Bone Joint J . 2020 ; 102-B ( 7_Supple_B ): 71 77 . Crossref PubMed Google Scholar

48. Dodds MK , Daly A , Ryan K , D'Souza L . Effectiveness of 'in-cast' pneumatic intermittent pedal compression for the pre-operative management of closed ankle fractures: a clinical audit . Foot Ankle Surg . 2014 ; 20 ( 1 ): 40 43 . Crossref PubMed Google Scholar

49. Thordarson DB , Greene N , Shepherd L , Perlman M . Facilitating edema resolution with a foot pump after calcaneus fracture . J Orthop Trauma . 1999 ; 13 ( 1 ): 43 46 . Crossref PubMed Google Scholar

50. Thordarson DB , Ghalambor N , Perlman M . Intermittent pneumatic pedal compression and edema resolution after acute ankle fracture: a prospective, randomized study . Foot Ankle Int . 1997 ; 18 ( 6 ): 347 350 . Crossref PubMed Google Scholar

51. Alkner BA , Halvardsson C , Bråkenhielm G , Eskilsson T , Andersson E , Fritzell P . Effect of postoperative pneumatic compression after volar plate fixation of distal radial fractures: a randomized controlled trial . J Hand Surg Eur Vol . 2018 ; 43 ( 8 ): 825 831 . Crossref PubMed Google Scholar

52. Yamazaki H , Hayashi M , Miyaoka S , et al. Venous perfusion assist system has no additional effect compared to simple elevation on post-operative edema in patients with distal radial fracture treated with volar locking plate fixation: a randomized controlled trial . J Orthop Sci . 2019 ; 24 ( 3 ): 441 446 . Crossref PubMed Google Scholar

53. Arndt KB , Jordy A , Viberg B . Can intermittent pneumatic compression (IPC) reduce time to surgery for malleolar fractures? Injury . 2018 ; 49 ( 3 ): 731 732 . Crossref PubMed Google Scholar

54. Stranks GJ , MacKenzie NA , Grover ML , Fail T . The A-V impulse system reduces deep-vein thrombosis and swelling after hemiarthroplasty for hip fracture . J Bone Joint Surg Br . 1992 ; 74-B ( 5 ): 775 778 . Crossref PubMed Google Scholar

55. Braithwaite I , De Ruyter B , Semprini A , et al. Cohort feasibility study of an intermittent pneumatic compression device within a below-knee cast for the prevention of venous thromboembolism . BMJ Open . 2016 ; 6 ( 10 ): e012764 . Crossref PubMed Google Scholar

56. Tull F , Borrelli J . Soft-Tissue injury associated with closed fractures: evaluation and management . J Am Acad Orthop Surg . 2003 ; 11 ( 6 ): 431 438 . Crossref PubMed Google Scholar

57. Ronga M , Shanmugam C , Longo UG , Oliva F , Maffulli N . Minimally invasive osteosynthesis of distal tibial fractures using locking plates . Orthop Clin North Am . 2009 ; 40 ( 4 ): 499 504 . Crossref PubMed Google Scholar

58. Bansal S , Kohli T , Aggarwal A , Jain A , Haq R . Change in Bohler and Gissane angles following open reduction and internal fixation without bone grafting for closed Sanders type 2 and 3 calcaneal fractures . International Journal of Orthopaedics . 2020 ; 6 ( 1 ): 162 166 . Google Scholar

59. Kumar A , Sahu SK . A comparative study of management of distal one third tibia fracture by low multidirectional locked nail and minimally invasive plate osteosynthesis (MIPO) . International Journal of Orthopaedics . 2020 ; 6 ( 1 ): 34 38 . Google Scholar

60. Lopas LA , Counihan MM , Donegan DJ . Open calcaneus fractures. fractures and dislocations of the talus and calcaneus . New York, New York, USA : Springer , 2020 : 239 250 . Google Scholar

61. Tosounidis TH , Pountos I , Giannoudis PV . Calcaneal fractures. fracture reduction and fixation techniques . New York, New York, USA : Springer , 2020 : 417 426 . Google Scholar

62. Yin Z , Wang Z , Ge D , Yan J , Jiang C , Liang B . Treatment of a high-energy transsyndesmotic ankle fracture . Injury . 2020 ; 99 ( 9 ): e19380 . Crossref PubMed Google Scholar

63. Sanders R . Intra-Articular fractures of the calcaneus: present state of the art . J Orthop Trauma . 1992 ; 6 ( 2 ): 252 265 . Crossref PubMed Google Scholar

Author contributions

M. Schnetzke: Designed and directed the study, Wrote the manuscript.

J. El Barbari: Wrote the manuscript.

S. Schüler: Performed the statistical analysis, Wrote the statistics section of the manuscript.

B. Swartman: Conducted the study.

H. Keil: Conducted the study.

S. Vetter: Conducted the study.

P. A. Gruetzner: Conducted the study.

J. Franke: Designed and directed the study.

Funding statement

The study was funded by OPED who also manufacture and market the vascular impulse technology device. Although none of the authors has received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article, benefits have been or will be received but will be directed solely to a research fund, foundation, educational institution, or other non-profit organization with which one or more of the authors are associated.

ICMJE COI statement

The authors declare an institutional grant from OPED, related to this study. M. Schnetzke also declares a grant from AO Trauma, unrelated to this study. S. Y. Vetter declares an institutional grant from Siemens Healthineers, related to this study.

Acknowledgements

We would like to thank Sarah Aytac and Daniel Matte for serving as independent observers to assess patient operability during daily rounds.

Ethical review statement

Approval was given by the Ethics Committee of the Rhineland-Palatinate State Medical Association (837.155.16/10474).

Open access statement

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND 4.0) licence, which permits the copying and redistribution of the work only, and provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc-nd/4.0/

Trial registration number

The study was registered in the German Clinical Trials Registry (DRKS00010510).

This article was primary edited by M. Hossain.